MY139844A - 1,2,4-triaminobenzene derivatives and their uses thereof for the prevention, treatment and/or inhibition of disorders of the central nervous system - Google Patents

1,2,4-triaminobenzene derivatives and their uses thereof for the prevention, treatment and/or inhibition of disorders of the central nervous system

Info

Publication number: MY139844A
Authority: MY; Malaysia
Prior art keywords: disorders; inhibition; prevention; treatment; nervous system
Prior art date: 2002-12-27

Application number

MYPI20035008A

Other languages

English (en)

Inventor

Mario Rottlander

Andreas Ritzen

Morten Bang Noergaard

Nikolay Khanzhin

Christian Wenzel Tornoee

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-27

Filing date

2003-12-26

Publication date

2009-11-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35295526&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY139844(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-12-26 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2009-11-30 Publication of MY139844A publication Critical patent/MY139844A/en

Links

JSYBAZQQYCNZJE-UHFFFAOYSA-N benzene-1,2,4-triamine Chemical class NC1=CC=C(N)C(N)=C1 JSYBAZQQYCNZJE-UHFFFAOYSA-N 0.000 title abstract 2
210000003169 central nervous system Anatomy 0.000 title 1
230000005764 inhibitory process Effects 0.000 title 1
230000002265 prevention Effects 0.000 title 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/32—Oxygen atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

MYPI20035008A 2002-12-27 2003-12-26 1,2,4-triaminobenzene derivatives and their uses thereof for the prevention, treatment and/or inhibition of disorders of the central nervous system MY139844A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DKPA200202012		2002-12-27

Publications (1)

Publication Number	Publication Date
MY139844A true MY139844A (en)	2009-11-30

Family

ID=35295526

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MYPI20035008A MY139844A (en)	2002-12-27	2003-12-26	1,2,4-triaminobenzene derivatives and their uses thereof for the prevention, treatment and/or inhibition of disorders of the central nervous system

Country Status (16)

Country	Link
KR (1)	KR20050089862A (is)
CN (1)	CN100448867C (is)
AR (1)	AR042656A1 (is)
BR (1)	BR0317748A (is)
CL (1)	CL2003002748A1 (is)
EA (1)	EA008589B1 (is)
IS (1)	IS2649B (is)
MY (1)	MY139844A (is)
NO (1)	NO20053612L (is)
PE (1)	PE20041015A1 (is)
PL (1)	PL377221A1 (is)
SI (1)	SI1578740T1 (is)
TW (1)	TWI325414B (is)
UA (1)	UA79666C2 (is)
UY (1)	UY28151A1 (is)
ZA (1)	ZA200504565B (is)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4200259A1 (de) *	1992-01-08	1993-07-15	Asta Medica Ag	Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung
DE19539861A1 (de) *	1995-10-26	1997-04-30	Asta Medica Ag	Verwendung von 4-Amino-4-(4-fluorbenzylamino)-1-ethoxy-carbonylaminobenzen zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen
GB9915414D0 (en) *	1999-07-01	1999-09-01	Glaxo Group Ltd	Medical use
US6117900A (en) *	1999-09-27	2000-09-12	Asta Medica Aktiengesellschaft	Use of retigabine for the treatment of neuropathic pain
US6589986B2 (en) *	2000-12-20	2003-07-08	Wyeth	Methods of treating anxiety disorders

2003
- 2003-12-18 KR KR1020057012183A patent/KR20050089862A/ko not_active Ceased
- 2003-12-18 PL PL377221A patent/PL377221A1/pl unknown
- 2003-12-18 BR BR0317748-3A patent/BR0317748A/pt not_active IP Right Cessation
- 2003-12-18 CN CNB2003801076953A patent/CN100448867C/zh not_active Expired - Fee Related
- 2003-12-18 EA EA200501053A patent/EA008589B1/ru not_active IP Right Cessation
- 2003-12-18 SI SI200330827T patent/SI1578740T1/sl unknown
- 2003-12-18 UA UAA200507206A patent/UA79666C2/uk unknown
- 2003-12-18 TW TW092135930A patent/TWI325414B/zh not_active IP Right Cessation
- 2003-12-22 AR ARP030104782A patent/AR042656A1/es unknown
- 2003-12-24 CL CL200302748A patent/CL2003002748A1/es unknown
- 2003-12-24 UY UY28151A patent/UY28151A1/es not_active Application Discontinuation
- 2003-12-26 MY MYPI20035008A patent/MY139844A/en unknown
2004
- 2004-01-05 PE PE2004000037A patent/PE20041015A1/es not_active Application Discontinuation
2005
- 2005-05-23 IS IS7856A patent/IS2649B/is unknown
- 2005-06-03 ZA ZA200504565A patent/ZA200504565B/xx unknown
- 2005-07-25 NO NO20053612A patent/NO20053612L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
BR0317748A (pt)	2005-11-22
IS7856A (is)	2005-05-23
CN100448867C (zh)	2009-01-07
PL377221A1 (pl)	2006-01-23
ZA200504565B (en)	2006-08-30
NO20053612D0 (no)	2005-07-25
KR20050089862A (ko)	2005-09-08
AR042656A1 (es)	2005-06-29
SI1578740T1 (sl)	2007-08-31
NO20053612L (no)	2005-09-23
UA79666C2 (en)	2007-07-10
TWI325414B (en)	2010-06-01
TW200413280A (en)	2004-08-01
UY28151A1 (es)	2004-07-30
PE20041015A1 (es)	2005-01-08
IS2649B (is)	2010-08-15
EA200501053A1 (ru)	2005-12-29
CN1732162A (zh)	2006-02-08
CL2003002748A1 (es)	2005-04-08
HK1088317A1 (zh)	2006-11-03
EA008589B1 (ru)	2007-06-29

Similar Documents

Publication	Publication Date	Title
DK1578740T3 (da)	2007-07-30	1,2,4-triaminobenzenderivater, der er egnede til behandling af lidelser i centralnervesystemet
BG106586A (en)	2003-01-31	Pyrazolopyramidines as therapeutic agents
MY141661A (en)	2010-05-31	17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
BG108268A (en)	2005-04-30	Pyrazolopyrimidines as therapeutic agents
JO2372B1 (en)	2006-12-12	Source drugs of 4-phenylpyridine derivatives
BG108269A (en)	2004-12-30	Pyrazolopyrimidines as therapeutic agents
MXPA05009359A (es)	2005-11-04	Tetrahidroisoquinolinas 2,5- y 2,6 substituidas para uso como moduladores 5-ht6.
GEP20053600B (en)	2005-08-10	3-(4-Amidopyrrol-2-Ylmethlidene)-2- Indolinone Derivatives as Protein Kinase Inhibitors
CA2534549A1 (en)	2005-03-24	Pteridine derivatives for the treatment of septic shock and tnf-.alpha.-related diseases.
MY124786A (en)	2006-07-31	Bis-arylsulfones
ATE360633T1 (de)	2007-05-15	N-substituierte hydromorphone und ihre anwendung
MXPA05010000A (es)	2005-11-17	Derivados de p-diaminobenceno substituidos.
IL155589A0 (en)	2003-11-23	Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
GB9923077D0 (en)	1999-12-01	Sapogenin derivatives and their use
IN2005KO00312A (is)	2015-08-14
WO2002018379A3 (en)	2002-07-25	7-oxo pyridopyrimidines
TW200505443A (en)	2005-02-16	Combination of SCR kinase inhibitors and chemotherapeutic agents for the treatment of proliferative diseases
DE50211929D1 (en)	2008-04-30	Pyrimidinderivate
BG105962A (en)	2002-05-31	Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders
DE69917005D1 (de)	2004-06-09	Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
PT1534296E (pt)	2011-08-18	UTILIZAÇÃO DE CILOBRADINA OU DOS SEUS SAIS FARMACEUTICAMENTE ACEITÁVEIS PARA O TRATAMENTO OU PREVENÇÃO DA INSUFICIjNCIA CARDÍACA
MY139844A (en)	2009-11-30	1,2,4-triaminobenzene derivatives and their uses thereof for the prevention, treatment and/or inhibition of disorders of the central nervous system
BG108164A (en)	2004-07-30	Glyt-1 inhibitors
DK1196176T3 (da)	2004-06-14	Anvendelse af beta-naphthoquinonderivater til fremstilling af lægemidler, der har en hæmmende virkning på hjernens afgivelse af glutamat
NO20012538D0 (no)	2001-05-23	Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet